The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Sarcoma, Kaposi

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Sarcoma, Kaposi


Psychiatry related information on Sarcoma, Kaposi


High impact information on Sarcoma, Kaposi


Chemical compound and disease context of Sarcoma, Kaposi


Biological context of Sarcoma, Kaposi


Anatomical context of Sarcoma, Kaposi


Gene context of Sarcoma, Kaposi


Analytical, diagnostic and therapeutic context of Sarcoma, Kaposi


  1. Monoclonal origin of multicentric Kaposi's sarcoma lesions. Rabkin, C.S., Janz, S., Lash, A., Coleman, A.E., Musaba, E., Liotta, L., Biggar, R.J., Zhuang, Z. N. Engl. J. Med. (1997) [Pubmed]
  2. Elevated serum thymosin alpha 1 levels associated with evidence of immune dysregulation in male homosexuals with a history of infectious diseases or Kaposi's sarcoma. Hersh, E.M., Reuben, J.M., Rios, A., Mansell, P.W., Newell, G.R., McClure, J.E., Goldstein, A.L. N. Engl. J. Med. (1983) [Pubmed]
  3. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. Yang, T.Y., Chen, S.C., Leach, M.W., Manfra, D., Homey, B., Wiekowski, M., Sullivan, L., Jenh, C.H., Narula, S.K., Chensue, S.W., Lira, S.A. J. Exp. Med. (2000) [Pubmed]
  4. HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection. Scorza Smeraldi, R., Fabio, G., Lazzarin, A., Eisera, N.B., Moroni, M., Zanussi, C. Lancet (1986) [Pubmed]
  5. Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial. Lane, H.C., Falloon, J., Walker, R.E., Deyton, L., Kovacs, J.A., Masur, H., Banks, S., Kirk, L.E., Baseler, M.W., Salzman, N.P. Ann. Intern. Med. (1989) [Pubmed]
  6. The AIDS dilemma: drug diseases blamed on a passenger virus. Duesberg, P., Rasnick, D. Genetica (1998) [Pubmed]
  7. Kaposi sarcoma in the acquired immune deficiency syndrome (AIDS), presenting as lymphogranuloma venereum (LGV) in a promiscuous trinidadian male. Aghadiuno, P.U., Jankey, N., Barton, E.N., Patrick, A.L., Roberts, L., Charles, W., Hull-Drysdale, B., Hinds, G. Tropical and geographical medicine. (1987) [Pubmed]
  8. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. Martin, D.F., Kuppermann, B.D., Wolitz, R.A., Palestine, A.G., Li, H., Robinson, C.A. N. Engl. J. Med. (1999) [Pubmed]
  9. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. Miller, G., Rigsby, M.O., Heston, L., Grogan, E., Sun, R., Metroka, C., Levy, J.A., Gao, S.J., Chang, Y., Moore, P. N. Engl. J. Med. (1996) [Pubmed]
  10. Butyl nitrite in the induction of Kaposi's sarcoma in AIDS. Mirvish, S.S., Haverkos, H.W. N. Engl. J. Med. (1987) [Pubmed]
  11. Cutaneous reaction to trimethoprim-sulfamethoxazole in patients with AIDS and Kaposi's sarcoma. Mitsuyasu, R., Groopman, J., Volberding, P. N. Engl. J. Med. (1983) [Pubmed]
  12. Amyl nitrite and Kaposi's sarcoma in homosexual men. Jørgensen, K.A., Lawesson, S.O. N. Engl. J. Med. (1982) [Pubmed]
  13. Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcoma. Pluda, J.M., Shay, L.E., Foli, A., Tannenbaum, S., Cohen, P.J., Goldspiel, B.R., Adamo, D., Cooper, M.R., Broder, S., Yarchoan, R. J. Natl. Cancer Inst. (1993) [Pubmed]
  14. Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cells. Corbeil, J., Rapaport, E., Richman, D.D., Looney, D.J. J. Clin. Invest. (1994) [Pubmed]
  15. Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells. Liu, Z.Y., Ganju, R.K., Wang, J.F., Ona, M.A., Hatch, W.C., Zheng, T., Avraham, S., Gill, P., Groopman, J.E. J. Clin. Invest. (1997) [Pubmed]
  16. Pilot study of cimetidine in the treatment of Kaposi's sarcoma in patients with acquired immunodeficiency syndrome. Smith, T.J., Kaplowitz, L.G. J. Natl. Cancer Inst. (1991) [Pubmed]
  17. Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma. Presant, C.A., Scolaro, M., Kennedy, P., Blayney, D.W., Flanagan, B., Lisak, J., Presant, J. Lancet (1993) [Pubmed]
  18. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. Stürzl, M., Hohenadl, C., Zietz, C., Castanos-Velez, E., Wunderlich, A., Ascherl, G., Biberfeld, P., Monini, P., Browning, P.J., Ensoli, B. J. Natl. Cancer Inst. (1999) [Pubmed]
  19. Fibroblast growth factor 6 gene expression in AIDS-associated Kaposi's sarcoma. Huang, Y.Q., Li, J.J., Nicolaides, A., Zhang, W.G., Freidman-Kien, A.E. Lancet (1992) [Pubmed]
  20. The N-terminal propiece of interleukin 1 alpha is a transforming nuclear oncoprotein. Stevenson, F.T., Turck, J., Locksley, R.M., Lovett, D.H. Proc. Natl. Acad. Sci. U.S.A. (1997) [Pubmed]
  21. The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium. Haque, N.S., Fallon, J.T., Taubman, M.B., Harpel, P.C. Blood (2001) [Pubmed]
  22. Role of Pax2 in apoptosis resistance and proinvasive phenotype of Kaposi's sarcoma cells. Buttiglieri, S., Deregibus, M.C., Bravo, S., Cassoni, P., Chiarle, R., Bussolati, B., Camussi, G. J. Biol. Chem. (2004) [Pubmed]
  23. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Boshoff, C., Endo, Y., Collins, P.D., Takeuchi, Y., Reeves, J.D., Schweickart, V.L., Siani, M.A., Sasaki, T., Williams, T.J., Gray, P.W., Moore, P.S., Chang, Y., Weiss, R.A. Science (1997) [Pubmed]
  24. Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex. Ellis, M., Chew, Y.P., Fallis, L., Freddersdorf, S., Boshoff, C., Weiss, R.A., Lu, X., Mittnacht, S. EMBO J. (1999) [Pubmed]
  25. Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate. Olwin, B.B., Rapraeger, A. J. Cell Biol. (1992) [Pubmed]
  26. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Jussila, L., Valtola, R., Partanen, T.A., Salven, P., Heikkilä, P., Matikainen, M.T., Renkonen, R., Kaipainen, A., Detmar, M., Tschachler, E., Alitalo, R., Alitalo, K. Cancer Res. (1998) [Pubmed]
  27. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Cai, J., Gill, P.S., Masood, R., Chandrasoma, P., Jung, B., Law, R.E., Radka, S.F. Am. J. Pathol. (1994) [Pubmed]
  28. Oncostatin-M stimulates tyrosine protein phosphorylation in parallel with the activation of p42MAPK/ERK-2 in Kaposi's cells. Evidence that this pathway is important in Kaposi cell growth. Amaral, M.C., Miles, S., Kumar, G., Nel, A.E. J. Clin. Invest. (1993) [Pubmed]
  29. An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Foster, C.B., Lehrnbecher, T., Samuels, S., Stein, S., Mol, F., Metcalf, J.A., Wyvill, K., Steinberg, S.M., Kovacs, J., Blauvelt, A., Yarchoan, R., Chanock, S.J. Blood (2000) [Pubmed]
  30. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study. Cianfrocca, M., Cooley, T.P., Lee, J.Y., Rudek, M.A., Scadden, D.T., Ratner, L., Pluda, J.M., Figg, W.D., Krown, S.E., Dezube, B.J. J. Clin. Oncol. (2002) [Pubmed]
  31. c-Src mediates mitogenic signals and associates with cytoskeletal proteins upon vascular endothelial growth factor stimulation in Kaposi's sarcoma cells. Munshi, N., Groopman, J.E., Gill, P.S., Ganju, R.K. J. Immunol. (2000) [Pubmed]
  32. Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells. Davis, M.A., Stürzl, M.A., Blasig, C., Schreier, A., Guo, H.G., Reitz, M., Opalenik, S.R., Browning, P.J. J. Natl. Cancer Inst. (1997) [Pubmed]
  33. Regression of Kaposi's sarcoma in AIDS after treatment with dapsone. Poulsen, A., Hultberg, B., Thomsen, K., Wantzin, G.L. Lancet (1984) [Pubmed]
  34. Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy. Northfelt, D.W., Dezube, B.J., Thommes, J.A., Levine, R., Von Roenn, J.H., Dosik, G.M., Rios, A., Krown, S.E., DuMond, C., Mamelok, R.D. J. Clin. Oncol. (1997) [Pubmed]
  35. Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study. Shepherd, F.A., Beaulieu, R., Gelmon, K., Thuot, C.A., Sawka, C., Read, S., Singer, J. J. Clin. Oncol. (1998) [Pubmed]
  36. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Ogawa, K., Pasqualini, R., Lindberg, R.A., Kain, R., Freeman, A.L., Pasquale, E.B. Oncogene (2000) [Pubmed]
WikiGenes - Universities